🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Allergen Immunotherapy

Pathway to Peanut Tolerance NCT07592780NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Peanut Oral Immunotherapy (OIT) Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy NCT06834165Phase 46 sites📍 La Jolla📍 Washington D.C.📍 Glenview ARS Pharmaceuticals, Inc. · Tests: Neffy, Adrenaline Identification of B Regulatory Cells by Flow Cytometry NCT06876506n/a1 site📍 Hull Hull University Teaching Hospitals NHS Trust · Tests: Venepuncture, Allergen Specific Immunotherapy, Allergen Specific Immunotherapy PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis NCT07563439Phase 21 site📍 Almaty Kazakh National Agrarian University · Tests: Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant, Montanide ISA-51 placebo emulsion Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma NCT06960382Phase 1, Phase 21 site📍 Zurich University of Zurich · Tests: ALUTARD SQ® Felis domesticus The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy NCT04544774n/a2 sites📍 Leuven📍 Bruges Universitaire Ziekenhuizen KU Leuven · Tests: AIT, NAPT The NACHO Trial (Nut Allergy Children OIT) NCT06930950NA1 site📍 Helsinki HUS Skin and Allergy Hospital · Tests: Cashew nut oral immunotherapy Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis NCT07726147Phase 11 site📍 Tokyo Immunomic Therapeutics, Inc. · Tests: ITI-9001, Placebo The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma NCT07452380n/a1 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… LYmph Node eXamination in Cat Allergen Immunotherapy NCT07447869EARLY Phase 11 site📍 Boston National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Intradermal cat allergen challenge Intratonsillar Immunotherapy for Allergic Rhinitis NCT06523478NA1 site📍 Wuhan Xu Yu · Tests: Intratonsillar immunotherapy (ITIT), Subcutaneous immunotherapy (SCIT) Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study NCT06778213Phase 41 site📍 Wroclaw Wroclaw Medical University · Tests: NovoHelisen Depot Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project NCT07419230NA1 site📍 Madrid Fundación de Investigación Biomédica - Hospital Universitar… · Tests: Active Adherence-booster App, Inactive Adherence-booster App Italian Registry of Allergen ImmunoTherapy NCT06499480n/a2 sites📍 Rozzano📍 Florence Società Italiana di Allergologia, Asma e Immunologia Clinica
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy